Total: 5 |
|
PMID (PMCID) | ||
---|---|---|
21103203 (2988856) |
OTHER | |
Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis: Abscess Formation in the Tumor Leading to Bacteremia and Seizure. | ||
Kitagawa M, Koh T, Nakagawa N, Kondo Y, Nishio M, Oguro A, Sakakura C, Nanri M, Otsuji E. Case Rep Gastroenterol. 2010;4(3):435-442. |
||
A 66-year-old woman with neurofibromatosis type 1 (NF1) was brought to the emergency room with seizures and high-grade fever. | ||
18692899 |
MALE | Adult |
[Ectasic diffuse vasculopathy of the cerebral arteries associated with neurofibromatosis type 1]. | ||
Bassou D, Darbi A, Atmane M, Jidal M, Elfenni J, Amezyane T, Benameur M, Elkharras A. J Neuroradiol. 2008;35(5):292-6. |
||
We report an original case of ectasic diffuse vasculopathy of the cerebral arteries associated with neurofibromatosis type 1 in a 43-year-old man presented with seizures. | ||
11247415 |
MALE | Child |
[Epileptic seizure as the first neurologic symptom of Recklinghausen disease in a 10-year old boy with a brain tumor]. | ||
Zajadacz B, Juszkiewicz A, Bartnicka K. Wiad Lek. 2000;53(11-12):697-700. |
||
Epileptic seizure as the first neurological symptom in von Recklinghausen disease (Neurofibromatosis type 1, NF 1) in 10 year old boy with cerebral tumour was described. | ||
11247415 |
MALE | Child |
[Epileptic seizure as the first neurologic symptom of Recklinghausen disease in a 10-year old boy with a brain tumor]. | ||
Zajadacz B, Juszkiewicz A, Bartnicka K. Wiad Lek. 2000;53(11-12):697-700. |
||
Epileptic seizure as the first neurological symptom in von Recklinghausen disease (Neurofibromatosis type 1, NF 1) in 10 year old boy with cerebral tumour was described. | ||
7798976 |
MIXED_SAMPLE | Child |
Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET. | ||
Balestri P, Lucignani G, Fois A, Magliani L, Calistri L, Grana C, Di Bartolo RM, Perani D, Fazio F. J Neurol Neurosurg Psychiatry. 1994;57(12):1479-83. |
||
Cerebral PET with [18F]-2-fluoro-2-deoxy-D-glucose has been performed in four patients with neurofibromatosis type 1 (NF1) to assess the relation between cerebral metabolic activity, MRI, and the presence of neurological symptoms, including seizures, as well as mental and language retardation. |